Reimbursemen of anti-migraine medication worldwide 2011

This statistic displays the reimbursement of specific migraine medications worldwide as of 2011. In 40 percent of responding countries, the expenses for anti-migraine drug Ergotamine were reimbursed, while in 23 percent of countries the reimbursement was in part.

Reimbursement of anti-migraine medication worldwide as of 2011, by drug type*

Characteristic	Yes	In part	No
Ergotamine	40	23	37
Almotriptan	33	29	38
Eletriptan	32	32	35
Frovatriptan	50	17	33
Naratriptan	32	35	32
Rizatriptan	43	27	30
Sumatriptan	38	28	34
Zolmitriptan	38	32	30

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

2011

More information

Region

Worldwide, Asia, Europe

Survey time period

as of 2011

Age group

Supplementary notes

* The source states that information was collected in a questionnaire survey of neurologists, general practitioners and patients’ representatives from 101 countries, performed from October 2006 until March 2009. Epidemiological data were compiled from published studies through a systematic review, and supplemented by data gathered in population-based studies undertaken within the Global Campaign.

Citation formats